sb 200646 has been researched along with sr 46349b in 1 studies
Studies (sb 200646) | Trials (sb 200646) | Recent Studies (post-2010) (sb 200646) | Studies (sr 46349b) | Trials (sr 46349b) | Recent Studies (post-2010) (sr 46349b) |
---|---|---|---|---|---|
24 | 0 | 5 | 51 | 1 | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marcoli, M; Maura, G; Raiteri, M; Tortarolo, M | 1 |
1 other study(ies) available for sb 200646 and sr 46349b
Article | Year |
---|---|
Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in rat cerebellum: involvement of 5-hydroxytryptamine2C receptors.
Topics: Adrenergic alpha-Antagonists; Animals; Cerebellum; Cyclic GMP; Excitatory Amino Acid Agonists; Fluorobenzenes; Indoles; Male; N-Methylaspartate; Nitric Oxide; Organ Culture Techniques; Phenols; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Urea; Yohimbine | 1997 |